Recent large-scale studies from Nordic countries and other global research centers have revealed that babies born through Assisted Reproductive Technology (ART) — including In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) — have a significantly higher risk of developing congenital heart defects (CHDs) compared to naturally conceived babies.
Key Research Findings
- A Nordic population study (2024) involving 7.7 million births found that:
- The risk of major congenital heart defects was 36% higher in ART-conceived children.
- The absolute risk increased from 1.15% (natural conception) to 1.84% (IVF/ART conception).
- The elevated risk was found regardless of the method used — whether it was fresh or frozen embryo transfer, or IVF vs. ICSI.
- These findings were published and supported by the European Society of Cardiology (ESC) and News-Medical.net (2024–2025).
Possible Reasons Behind the Risk
-
Embryo Manipulation & Laboratory Conditions
- During IVF, embryos are fertilized and grown in artificial culture mediums, which may slightly affect cellular development and organ formation.
-
Parental Infertility Factors
- Infertility itself can be linked to genetic or health issues in parents that could influence the baby’s heart development.
-
Advanced Maternal Age
- Many IVF patients are older, and advanced maternal age is a known risk factor for chromosomal abnormalities that can lead to heart defects.
-
Multiple Births (Twins/Triplets)
- IVF often results in multiple pregnancies, which are associated with preterm birth, low birth weight, and congenital malformations.
-
Epigenetic Modifications
- ART procedures might slightly alter how genes are turned on or off during early embryo growth, possibly influencing cardiac gene expression.
Types of Heart Defects Observed
Some of the commonly reported congenital heart defects in IVF/ART babies include:
- Septal defects (holes in the heart walls)
- Tetralogy of Fallot (a combination of four heart defects)
- Transposition of great arteries (TGA)
- Pulmonary valve or aortic valve stenosis
How to Reduce the Risk
- Opt for Single Embryo Transfer (SET) to minimize multiple pregnancies.
- Ensure pre-pregnancy health optimization – manage weight, diabetes, thyroid, and blood pressure before IVF.
- Avoid teratogenic medications (harmful to the fetus) during early pregnancy.
- Use preimplantation genetic testing (PGT) to screen embryos for chromosomal or genetic issues.
- Fetal echocardiography – specialized heart scanning during pregnancy to detect heart issues early.
- Reduce stress and maintain a healthy lifestyle throughout IVF treatment and pregnancy.
Global Expert View
- Experts emphasize that although there is a measurable increase in heart defect risk, the absolute risk remains small — most IVF babies are born healthy.
- The findings are not meant to discourage IVF but to promote awareness and better prenatal care for early detection and prevention.
Conclusion
The link between IVF/ART and congenital heart defects is a crucial finding in reproductive medicine. It highlights the need for:
- Comprehensive parental counseling,
- Improved embryo culture technologies, and
- Early cardiac monitoring of ART-conceived infants.
With proper medical care and monitoring, IVF remains a safe and life-changing option for millions of couples struggling with infertility.